Intec Pharma Ltd (NASDAQ:NTEC)’s share price gapped up prior to trading on Tuesday . The stock had previously closed at $4.36, but opened at $4.47. Intec Pharma shares last traded at $4.58, with a volume of 14,056 shares changing hands.

Several brokerages have weighed in on NTEC. Zacks Investment Research cut Intec Pharma from a “hold” rating to a “sell” rating in a report on Tuesday, July 12th. Maxim Group reaffirmed a “buy” rating and issued a $9.00 price objective on shares of Intec Pharma in a report on Tuesday, April 5th.

The company has a 50-day moving average price of $4.52 and a 200-day moving average price of $4.10. The firm’s market capitalization is $52.89 million.

Intec Pharma Ltd is an Israel-based drug development company. It is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel gastro-retentive delivery system, improves the pharmacokinetics and pharmacodynamics of various drugs.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.